María L López-Rodríguez

A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists.

Leonardo Pardo, Bellinda Benhamú, Mercedes Campillo, 2005, Journal of medicinal chemistry.

Blocking Ras inhibition as an antitumor strategy.

M. López-Rodríguez, S. Ortega‐Gutiérrez, María L López-Rodríguez, 2018, Seminars in cancer biology.

Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.

Jessica Sallander, Leonardo Pardo, Bellinda Benhamú, 2010, Journal of medicinal chemistry.

Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

Leonardo Pardo, Bellinda Benhamú, L. Pardo, 2014, Journal of medicinal chemistry.

Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.

Jessica Sallander, Leonardo Pardo, Bellinda Benhamú, 2009, Journal of medicinal chemistry.

The extracellular entrance provides selectivity to serotonin 5-HT7 receptor antagonists with antidepressant-like behavior in vivo.

Gianluigi Caltabiano, Leonardo Pardo, Bellinda Benhamú, 2014, Journal of medicinal chemistry.